Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First birth control patch Ortho Evra launched

May 2, 2002

NeuroSearch will not advance NS-3728 into phase II for sickle cell anemia

May 2, 2002

FDA approves recommended starting doses of atorvastatin

May 2, 2002

First launch for Neulasta in April

May 2, 2002

Selective estrogens with preference for the ERalpha receptor claimed by Jenapharm

April 30, 2002

DiAthegen and TissueInformatics form obesity and type 2 diabetes joint venture

April 30, 2002

Dihydropyridine Y1 receptor antagonists reduce food intake in rat models

April 30, 2002

FDA alerts to Actos and Avandia label modifications

April 30, 2002

New Ilex compounds lower apolipoprotein and cholesterol levels

April 29, 2002

New 5-HT1A ligands and monoamine reuptake inhibitors and their therapeutic applications

April 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...